Results 101 to 110 of about 21,845 (197)

A combinatorial oligonucleotide therapy to improve dystrophin restoration and dystrophin-deficient muscle health

open access: yesMolecular Therapy: Nucleic Acids
Despite the proven safety of dystrophin-targeting phosphorodiamidate morpholino oligomer (PMO) therapy, poor delivery of the PMOs limit the efficacy of this dystrophin restoring gene therapy for Duchenne muscular dystrophy (DMD).
Young Jae Moon   +6 more
doaj   +1 more source

Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy

open access: yesScientific Reports
Delandistrogene moxeparvovec is an rAAVrh74 vector-based gene transfer therapy that delivers a transgene encoding delandistrogene moxeparvovec micro-dystrophin, an engineered, functional form of dystrophin shown to stabilize or slow disease progression ...
Rachael A. Potter   +14 more
doaj   +1 more source

Engineering suppressor tRNAs for effective treatment of Duchenne muscular dystrophy. [PDF]

open access: yesSci Adv
Oury J   +19 more
europepmc   +1 more source

Four new mouse models of Duchenne muscular dystrophy with clinically relevant exon deletions in the human DMD gene. [PDF]

open access: yesDis Model Mech
van Putten M   +9 more
europepmc   +1 more source

Duchenne muscular dystrophy: from gene to gene-ius therapies. [PDF]

open access: yesSkelet Muscle
Muchir A, Musaro A, Chamberlain J.
europepmc   +1 more source

Home - About - Disclaimer - Privacy